Medical Devices and Pharma

Medical device and pharmaceutical regulatory consulting and health safety information

Headlines

Urgent Recall: Dr. Reddy’s Levetiracetam Injection

What You Need to Know Dr. Reddy’s Laboratories has issued an urgent recall for one batch (Lot No: A1540076) of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL due to a serious labeling error. The infusion bag is incorrectly labeled as Levetiracetam...

FDA Issues Warning on Epinephrine Nasal Solutions

Left: BPI Labs’ FDA-approved Epinephrine Injection with blue lid on the bottle.Right: BPI Labs’ unapproved EPINEPHrine Chloride Nasal Solution with red lid on the bottle.Courtesy: FDA.A Potentially Dangerous Mix-Up The U.S. Food and Drug Administration (FDA) has...

FDA Issues Warning on Counterfeit Botox Products 

Real Botox PackagingReal Botox Cosmetic PackagingReal Botox PackagingCounterfeit Botox Products  The U.S. Food and Drug Administration (FDA) has issued a critical alert concerning the presence of counterfeit Botox products in various states, posing severe risks to...

Health Alert Regarding Rare Pregnancy Complication

FDA Safety Communication   In a recent health safety alert, the U.S. Food and Drug Administration (FDA) has cautioned healthcare professionals about the rare risk of intrahepatic cholestasis of pregnancy (ICP) associated with the use of thiopurines, including...

FDA Alert: Baxter Recalls Spectrum Infusion Pumps

Baxter Spectrum Infusion Pump Alert Date: July 2025Device: Sigma Spectrum Infusion System (V6 and V8 Platforms)Manufacturer: Baxter HealthcareIssue Type: Urgent Medical Device RecallFDA Status: High-risk; active monitoring in progress The FDA has issued an early alert...

How Unsafe Medical Devices Can Slip Through the Cracks

Healthcare professionals and the device industry share responsibility for timely adverse event reportingGlobal device market withdrawals not always followed in US In a world of global trade and instant communication, you might assume that a medical device deemed...

Study Reveals Delays in Medical Device Adverse Event Reporting

Healthcare professionals and the device industry share responsibility for timely adverse event reportingLapses defeat the purpose of adverse event reporting A recent study published in the British Medical Journal has spotlighted a troubling trend: many medical device...

A QSR to QMSR Transition Strategy

QMSR Implementation Strategy for U.S. Medical Device Manufacturers Not in Compliance with ISO 14385:2016 Transitioning from the FDA’s Quality System Regulation (QSR; 21 CFR 820) to the Quality Management System Regulation (QMSR) is a significant undertaking that...

FDA Issues Warning on Epinephrine Nasal Solutions

Left: BPI Labs’ FDA-approved Epinephrine Injection with blue lid on the bottle.Right: BPI Labs’ unapproved EPINEPHrine Chloride Nasal Solution with red lid on the bottle.Courtesy: FDA.A Potentially Dangerous Mix-Up The U.S. Food and Drug Administration (FDA) has...

Generic Eliquis

Generic Eliquis Editor's note: FDA originally announced the approval of generic equivalents to Eliquis in 2019, and updated that information the next year. We are publishing this information as a response to reader requests for more information about generic Eliquis....

FDA Grants Accelerated Approval to Tarlatamab-dlle

Treatment for lung cancer with progression following platinum-based chemotherapy  On May 16, 2024, the Food and Drug Administration (FDA) granted accelerated approval to Imdelltra (tarlatamab-dlle) manufactured by Amgen, Inc. for the treatment of extensive stage small...

FDA Approves New Imaging Drug Lumisight  

A Significant Improvement for Surgical Oncology  The U.S. Food and Drug Administration (FDA) has granted approval to LumiSight (pegulicianine) for use in adults undergoing breast lumpectomy, marking a significant advancement in surgical oncology.   Lumisight, a...

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Has Industry Self-Regulation Been Effective? 

Has Industry Self-Regulation Been Effective?  Supplement industry self-regulation has helped in limited ways, but it has not been sufficient to ensure reliable safety.  What has worked  Voluntary GMP certifications (e.g., NSF, USP, Informed Choice)  A minority of...

Why DSHEA Reform Must Be a Priority 

Why DSHEA Reform Must Be a Priority   The recent wave of moringa-related contamination recalls – touching national retail chains and rippling through dozens of contract manufacturers – has forced an uncomfortable question into public view: How was a single tainted...

The 30-Year Consequences of Faulty Supplement Legislation

How a 1994 Law Created Today’s Dietary Supplement Crisis   In light of the current moringa contamination recalls affecting national retailers and dozens of downstream manufacturers, many consumers are asking the same question: How did this happen?  The answer leads us...

Invisible Outbreak of Contaminated Supplement Ingredients

Contaminated Products Distributed Nationwide  How a contaminated Moringa shipment was spread across the U.S. supplement market, and why there were no additional recalls.  Sam’s Club announced a recall of its Member’s Mark Super Greens powder in late October 2025 due...

Latest Posts

FDA Approves First Oral Treatment for Canine Lymphoma

Approval Granted With Minor Use/Major Species (MUMS) Pathway The U.S. Food and Drug Administration has granted full approval to Laverdia® (verdinexor tablets), the first FDA-approved oral treatment for lymphoma in dogs. Canine lymphoma is a cancer of the lymph nodes...

read more

FDA Grants Full Approval for Canine Epilepsy Drug

Approval Granted After Expanded Conditional Pathway The U.S. Food and Drug Administration has granted full approval to KBroVet® (potassium bromide chewable tablets) for the control of seizures in dogs diagnosed with idiopathic epilepsy, a chronic seizure disorder with...

read more

FDA Advisory for Contaminated Raaw Energy Dog Food

The U.S. Food and Drug Administration (FDA) has issued a public advisory warning pet owners not to feed eight identified lots of Raaw Energy dog food after testing confirmed contamination with multiple pathogenic bacteria, including Listeria monocytogenes, Salmonella,...

read more

FDA Approves First Generic Fenbendazole Oral Suspension

Defendazole™ (fenbendazole) 10% Oral Suspension The U.S. Food and Drug Administration has approved Defendazole™ (fenbendazole) 10% oral suspension, the first FDA-approved generic fenbendazole dewormer for use in beef and dairy cattle and goats. Defendazole is...

read more

FDA Approves First Generic for Bovine Respiratory Disease

nixiFLOR, the first generic version of Resflor GOLD The U.S. Food and Drug Administration has approved nixiFLOR, an injectable solution combining florfenicol and flunixin meglumine, for the treatment of bovine respiratory disease (BRD) and the control of...

read more

FDA Approves Drug to Delay Canine Congestive Heart Failure

Vetmedin is the first drug to go from an expanded conditional approval to fully approved The U.S. Food and Drug Administration has fully approved a new use for Vetmedin (pimobendan) chewable tablets, making it the first drug officially recognized to delay the onset of...

read more
Navigating the Transition from the QSR to the QMSR

Available in paperback and eBook formats on Amazon. 

Click on the image or this link to see the book on the Amazon website.

Welcome to Medical Devices and Pharma, a website dedicated to providing timely and relevant medical device and pharma information to the regulated medical device and pharmaceutical industries, and consumers of those products.

Our goal is to provide organized, clearly written information from regulatory affairs and consumer perspectives.

  • Key information from the Food and Drug Administration (FDA), the federal regulatory agency responsible for providing oversight over the industries and assuring the safety and efficacy of their products.
  • Regulatory services for compliance, market access, and crisis management
  • Information about innovation, including new products cleared for use in the U.S. market.
  • News stories with topics ranging from product issues to market trends.

Perhaps most importantly, we will strive to maintain vigilance over product issues and their impacts. Check back here for consumer news, product alerts, and current litigation.

Artificial Intelligence

Discover how Artificial Intelligence is revolutionizing the medical device and pharmaceutical industries.

Stay up-to-date with the latest advancements and breakthroughs that are shaping the future of healthcare.

QMSR - Quality Management System Regulation

The U.S. Food and Drug Administration (FDA) has introduced significant updates to its regulatory framework for medical device manufacturers with the transition from the Quality System Regulation (QSR) to the Quality Management System Regulation (QMSR).

This modernization aligns with global standards, streamlining compliance for manufacturers who market devices internationally while maintaining a strong focus on patient safety and product quality.

CDRH 2024 Safety Report

Interaction Between Regulatory and Quality Functions

Quality Management System Regulation - QMSR

Regulatory Information Management Systems - RIMS

CDRH Issues its 2024 Innovation Report

Medical Devices

Pharmaceuticals

Consumer Information

A veteran-owned business
located in
Iowa’s Cedar Valley